FindTrial
Sign In

To explore the distribution characteristics of differential genes and TCM syndrome types in colorectal cancer and adenoma patients based on Septin9 gene methylation

To explore the distribution characteristics of differential genes and TCM syndrome types in colorectal cancer and adenoma patients based on Septin9 gene methylation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200061491
Enrollment
Unknown
Registered
2022-06-27
Start date
2022-07-01
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer and adenoma

Interventions

Colorectal cancer group:None
Colorectal adenoma group:None

Sponsors

Wangjing Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. In line with Western diagnostic standards for colorectal cancer and adenoma. ? ? 2. Septin9 gene methylation test results were clear. 3. All cases were newly diagnosed patients who had not received surgery, radiotherapy or chemotherapy. ? ?

Exclusion criteria

Exclusion criteria: 1. Patients with other malignant tumors. 2. Patients with severe diseases of heart, cerebrovascular, liver, kidney, hematopoietic system and endocrine system. 3. Incomplete medical records. 4. Oral administration of Chinese medicine within 1 month before diagnosis affected TCM syndrome type. ?

Design outcomes

Primary

MeasureTime frame
Septin9 gene;—

Countries

China

Contacts

Public ContactGuo Xiaofei

Wangjing Hospital, China Academy of Chinese Medical Sciences

18614981801@163.com+86 18614981801

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026